Insider Trading June 11, 2026 07:31 PM

Qualcomm Executive Divests $493k in Company Stock Amid Valuation Debate

CFO Palkhiwala executes pre-arranged sale as analysts upgrade semiconductor giant on AI-driven growth prospects

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
QCOM

Akash J. Palkhiwala, Qualcomm's Executive Vice President, Chief Financial Officer, and Chief Operating Officer, sold 2,500 shares of common stock on June 11, 2026, generating $493,379. The transaction was conducted under a Rule 10b5-1 trading plan established on December 8, 2025. Following the sale, Palkhiwala holds 25,684 shares directly. The sale occurs as Qualcomm's stock trades at $202.96, reflecting a 16% decline over the preceding week. Despite the recent price drop, InvestingPro analysis suggests the stock may be undervalued, with a fair value estimate indicating potential upside. Qualcomm currently trades at a P/E ratio of 22.09 and commands a market capitalization of $214.38 billion.

Qualcomm Executive Divests $493k in Company Stock Amid Valuation Debate
QCOM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Qualcomm CFO Palkhiwala executed a $493k stock sale under a pre-arranged 10b5-1 plan, reducing his direct holdings to 25,684 shares.
  • Analysts Bernstein and Tigress Financial Partners have raised Qualcomm's price targets to $210 and $280 respectively, driven by AI smartphone adoption and a $20 billion buyback program.
  • Qualcomm's stock has declined 16% over the past week, trading at $202.96, though some analysis suggests it may be undervalued relative to fair value estimates.

Akash J. Palkhiwala, who serves as Executive Vice President, Chief Financial Officer, and Chief Operating Officer at QUALCOMM INC/DE (NASDAQ:QCOM), liquidated a portion of his equity holdings on June 11, 2026. The executive disposed of 2,500 shares of common stock, with the total proceeds from the transaction reaching $493,379. These sales were executed within a price range of $193.8062 to $203.2518 per share. The transactions were facilitated through a Rule 10b5-1 trading plan that Palkhiwala initiated on December 8, 2025. After completing these sales, Palkhiwala's direct ownership stake in Qualcomm common stock stands at 25,684 shares.

The insider transaction takes place against a backdrop of recent price volatility for Qualcomm. The stock was trading at $202.96 at the time of the report, marking a 16% decline over the preceding week. Despite this recent downward movement, analysis from InvestingPro indicates that the stock may currently be undervalued. The analysis suggests that the fair value estimate points to potential upside from current levels. Qualcomm currently maintains a price-to-earnings ratio of 22.09 and holds a market capitalization valued at $214.38 billion.

In parallel corporate developments, Neura Robotics recently announced a Series C financing round valued at up to $1.4 billion. The funding round is designed to expand Neura Robotics' Physical AI platform and includes participation from prominent investors such as Tether, Qualcomm Technologies, Inc., Amazon, and NVIDIA. This capital injection aims to enhance Neura Robotics' global deployment capabilities. Meanwhile, Qualcomm has received attention from market analysts. Bernstein upgraded its rating on the stock to Outperform from Market Perform, citing the company's leadership position in AI-enabled smartphone processors. Bernstein raised its price target to $210, highlighting the accelerating adoption of AI features in smartphones as a significant driver. Additionally, Tigress Financial Partners raised Qualcomm's price target to $280, maintaining a Buy rating. Tigress cited the company's transition to intelligent connectivity and a new $20 billion share buyback program as key factors.

Broader geopolitical developments include the announcement by a White House official that Elon Musk and Larry Fink are among the executives joining the US delegation to China. The delegation will also feature Boeing's Kelly Ortberg and GE Aerospace's chief executive.

Key Points:

  • Qualcomm CFO Palkhiwala executed a $493k stock sale under a pre-arranged 10b5-1 plan, reducing his direct holdings to 25,684 shares.
  • Analysts Bernstein and Tigress Financial Partners have raised Qualcomm's price targets to $210 and $280 respectively, driven by AI smartphone adoption and a $20 billion buyback program.
  • Qualcomm's stock has declined 16% over the past week, trading at $202.96, though some analysis suggests it may be undervalued relative to fair value estimates.

Risks and Uncertainties:

  • The recent 16% decline in Qualcomm's stock price over the past week introduces short-term volatility risk for investors, potentially impacting market sentiment despite long-term valuation metrics.
  • The reliance on accelerating AI feature adoption in smartphones as a growth driver creates exposure to consumer spending cycles and technological adoption rates within the consumer electronics sector.
  • The execution of a Rule 10b5-1 trading plan, while standard for compliance, may signal to the market that insiders are managing personal liquidity needs, which can sometimes be misinterpreted as a lack of confidence in near-term stock performance.

Risks

  • The recent 16% decline in Qualcomm's stock price over the past week introduces short-term volatility risk for investors, potentially impacting market sentiment despite long-term valuation metrics.
  • The reliance on accelerating AI feature adoption in smartphones as a growth driver creates exposure to consumer spending cycles and technological adoption rates within the consumer electronics sector.
  • The execution of a Rule 10b5-1 trading plan, while standard for compliance, may signal to the market that insiders are managing personal liquidity needs, which can sometimes be misinterpreted as a lack of confidence in near-term stock performance.

More from Insider Trading

Hippo Holdings CEO Richard McCathron Executes $125,000 Stock Sale Jun 11, 2026 CrowdStrike's CEO George Kurtz Offloads $1.74M in Shares Amid Strong Q1 Fiscal 2027 Results and Analyst Revisions Jun 11, 2026 Axsome Therapeutics Director Liquidates Holdings Following Pre-Arranged Plan Jun 11, 2026 BDX Executive Michael Garrison Offloads $166K in Stock Under Pre-Arranged Plan Jun 11, 2026 CrowdStrike CEO Kurtz Executes $1.49M Share Sale Under Pre-Arranged Plan Jun 11, 2026